SciDev (SDV.AX) Stock Price

SciDev Price

ASX·CLOSED
0.16AUD+0.0050 (+3.28 %)
Market closed

Revenue has compounded at 20.2% per year over the past 19 years to 103.23 M AUD. Earnings per share have declined at 13.5% per year over the last 13 years. SciDev's net margin stands at -0.9%, down from 8.1% several years earlier. Analysts set a median price target of 0.61 AUD, implying 294.8% above the current price. Of 5 analysts, 4 rate the stock a buy — an overall Buy consensus. The stock trades about 78% above its 52-week low.

SciDev stock price

Volume
Details

Stock Price

How to Read This Chart

This chart tracks the historical stock price of SciDev over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how SciDev stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing SciDev's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

SciDev Stock Price History
DateSciDev Price
9/4/20260.16 AUD
9/3/20260.15 AUD
9/2/20260.14 AUD
9/1/20260.16 AUD
8/31/20260.14 AUD
8/28/20260.15 AUD
8/27/20260.13 AUD
8/26/20260.15 AUD
8/25/20260.15 AUD
8/24/20260.17 AUD
8/21/20260.16 AUD
8/20/20260.17 AUD
8/19/20260.18 AUD
8/18/20260.17 AUD
8/17/20260.19 AUD
8/14/20260.19 AUD
8/13/20260.18 AUD
8/12/20260.17 AUD
8/11/20260.17 AUD
8/10/20260.17 AUD
8/7/20260.16 AUD
8/6/20260.17 AUD
8/5/20260.17 AUD
8/4/20260.14 AUD
8/3/20260.11 AUD
7/31/20260.11 AUD
7/30/20260.12 AUD
7/29/20260.12 AUD
7/28/20260.12 AUD
7/27/20260.11 AUD
Access this data via the Eulerpool API

SciDev Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2021
42.53 M AUD
-718,900.00 AUD
3.45 M AUD
Jan 1, 2022
55.60 M AUD
-315,000.00 AUD
-616,000.00 AUD
Jan 1, 2023
89.72 M AUD
571,000.00 AUD
-339,000.00 AUD
Jan 1, 2024
109.09 M AUD
4.77 M AUD
2.18 M AUD
Jan 1, 2025
103.23 M AUD
1.91 M AUD
-878,000.00 AUD
Jan 1, 2026 (e)
86.00 M AUD
1.45 M AUD
-1.01 M AUD
Jan 1, 2027 (e)
94.32 M AUD
1.59 M AUD
1.39 M AUD
Jan 1, 2028 (e)
108.45 M AUD
1.83 M AUD
2.36 M AUD

SciDev Income Statement, Balance Sheet, Cash Flow Statement

Last updated Sep 6, 2026, 7:54 AM
 
REVENUEM AUD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM AUD
EBITM AUD
EBIT MARGIN%
NET INCOMEM AUD
NET INCOME GROWTH%
SHARESM
20132014201520162017201820192020202120222023202420252026e2027e2028e
1.001.001.001.001.002.002.0018.0042.0055.0089.00109.00103.0086.0094.00108.00
-50.00100.00800.00133.3330.9561.8222.47-5.50-16.509.3014.89
100.00100.00100.00100.003,400.001,700.001,700.0016.6723.8130.9126.9730.2833.0133.0133.0133.01
1.001.001.001.0034.0034.0034.003.0010.0017.0024.0033.0034.0028.3931.0335.65
-1.00-1.00-1.00-2.00-2.004.001.001.001.001.00
-100.00-100.00-50.00-100.00-11.113.670.971.161.060.93
-2.00-1.001.00-2.003.002.00-1.001.002.00
-33.33-50.00-300.00-200.00100.00
32.2632.2632.2632.2641.5953.2975.68127.53154.75177.37189.68189.85189.98189.98189.98189.98
Details

Income Statement Key Figures

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales SciDev generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue SciDev retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare SciDev's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares SciDev has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against SciDev's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

SciDev stock margins

The SciDev margin analysis displays the gross margin, EBIT margin, as well as the profit margin of SciDev. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for SciDev.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
23.89 %
-1.69 %
8.12 %
Jan 1, 2022
31.32 %
-0.57 %
-1.11 %
Jan 1, 2023
26.95 %
0.64 %
-0.38 %
Jan 1, 2024
31.14 %
4.37 %
1.99 %
Jan 1, 2025
33.31 %
1.85 %
-0.85 %
Jan 1, 2026 (e)
33.31 %
1.69 %
-1.17 %
Jan 1, 2027 (e)
33.31 %
1.69 %
1.47 %
Jan 1, 2028 (e)
33.31 %
1.69 %
2.17 %

SciDev Stock Revenue, EBIT, Earnings per Share

The SciDev earnings per share therefore indicates how much revenue SciDev has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2021
0.27 AUD
-0.00 AUD
0.02 AUD
Jan 1, 2022
0.31 AUD
-0.00 AUD
-0.00 AUD
Jan 1, 2023
0.47 AUD
0.00 AUD
-0.00 AUD
Jan 1, 2024
0.57 AUD
0.03 AUD
0.01 AUD
Jan 1, 2025
0.54 AUD
0.01 AUD
-0.00 AUD
Jan 1, 2026 (e)
0.45 AUD
0.01 AUD
-0.01 AUD
Jan 1, 2027 (e)
0.50 AUD
0.01 AUD
0.01 AUD
Jan 1, 2028 (e)
0.57 AUD
0.01 AUD
0.01 AUD

SciDev business model & stock analysis

Scidev Ltd is a British corporation specializing in the development and production of products aimed at sustainably improving the quality of life for people in developing countries. The company is headquartered in Wallsend, near Newcastle-upon-Tyne. Scidev began with a modest budget of only 500 British pounds. The founders, Dr. David Fulford and Dr. Andrew Thompson, aimed to develop cost-effective solutions to address the problem of water scarcity in India and other developing countries. They started by developing simple water treatment technologies and worked closely with engineers and scientists from the region to perfect their technologies. Their first major success was the development and sale of water filters used in rural areas of India. Today, Scidev is a leading provider of products and solutions in the areas of water technology, health, agriculture, and renewable energy. The company has over 60 employees in the UK and subsidiaries in Switzerland, Kenya, and India. Scidev's business model is based on the principle that the needs of people in developing countries are best understood by locally-based companies. Scidev works closely with local engineers, scientists, and entrepreneurs to develop innovative solutions that meet the needs of their communities. The company provides training and support to its partners in product launch to ensure their products have a measurable impact on people's lives. One of Scidev's most successful divisions is water technology. The company offers a range of water purification systems tailored to different conditions and requirements. These include both low-cost systems like the Puddle Pump, which is particularly used in rural areas, and high-tech systems like the membrane filter, which is used in urban areas. Scidev also develops technologies in the health sector. An example is the immunochromatographic rapid test (ICT), used in the diagnosis and monitoring of diseases such as malaria, HIV, and tuberculosis. The ICT tests allow medical personnel to make quick and cost-effective diagnoses and track the success of treatments. In the agriculture division, Scidev offers solutions that enable farmers to increase their yields while protecting the environment. One example is the Biolizer XE, an organic-based fertilizer that provides a sustainable alternative to chemical fertilizers. The Biolizer XE was introduced in Kenya and has helped increase farmers' yields while reducing environmental impact from the use of chemical fertilizers. Scidev is also active in the development of renewable energy. The company has developed a range of products based on solar technology, such as solar lanterns and small solar networks. These products are particularly popular in rural areas where access to electricity is limited. Overall, Scidev is a company dedicated to improving the quality of life for people in developing countries. The company has successfully developed innovative technologies that address the challenges in these countries while providing viable business models. Scidev has established itself as a pioneer in the development of technologies that have a positive impact on people's lives.

SciDev SWOT Analysis

Strengths

Scidev Ltd possesses the following strengths:

  • Strong market reputation and brand recognition.
  • Advanced technological infrastructure and software solutions.
  • Highly skilled and experienced team of professionals.
  • Established partnerships with key industry players.
  • Efficient and streamlined internal processes.
  • Robust financial position and steady revenue growth.

Weaknesses

Scidev Ltd faces the following weaknesses:

  • Limited product diversification.
  • Relatively small market share compared to competitors.
  • Dependency on a specific customer segment.
  • Lack of global presence and market penetration.
  • Challenges in adapting to rapidly changing technology trends.
  • Potential vulnerabilities in data security and privacy.

Opportunities

Scidev Ltd should consider the following opportunities:

  • Growing market demand for advanced software solutions.
  • Expansion into new geographical markets.
  • Development of strategic partnerships with complementary businesses.
  • Integration of emerging technologies to enhance product offerings.
  • Leveraging data analytics to drive customer insights and innovation.

Threats

Scidev Ltd should be cautious of the following threats:

  • Intense competition and price pressures from rival firms.
  • Rapid technological advancements leading to product obsolescence.
  • Regulatory changes impacting industry operations and compliance.
  • Economic downturns affecting customer spending and budget cuts.
  • Intellectual property infringement and unauthorized data access.

SciDev Eulerpool Fair Value

Details

Fair Value Estimate

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

SciDev historical P/E ratio, EBIT multiple, and P/S ratio

SciDev annual returns

Details

Annual Return

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

SciDev shares outstanding

The number of shares of SciDev was 189.98 M in 2025. This indicates how many shares SciDev is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2021
154.75 M Stocks
Jan 1, 2022
177.37 M Stocks
Jan 1, 2023
189.68 M Stocks
Jan 1, 2024
189.85 M Stocks
Jan 1, 2025
189.98 M Stocks
Jan 1, 2026 (e)
189.98 M Stocks
Jan 1, 2027 (e)
189.98 M Stocks
Jan 1, 2028 (e)
189.98 M Stocks

SciDev stock splits

In SciDev's history, there have been no stock splits.

Current SciDev forecasts and price targets in September 2026

Analyst Price Targets 2026
Δ MOM Price Target
0.00 %
Buy
80.00 % (4)
Hold
20.00 % (1)
Sell
0.00 % (0)
12M Price Target
0.61
Last Price
0.16
Currency
AUD
12M Return Potential
294.84 %
LTM Return
0 %

SciDev Earnings Estimates & Surprises

DateEPS estimateEPS ActualRevenue EstimatePrice reactionQuarterly report
9/1/20220.01AUD-31.77 MAUD-2022 Q4
2/21/2022-0.00AUD-24.46 MAUD-2022 Q2
8/31/20210.01AUD-24.66 MAUD-2021 Q4
2/8/20210.30AUD-19.69 MAUD-2021 Q2
9/1/2008-AUD-14.21 MAUD-2008 Q4

SciDev shareholder structure

% Name
7.01035%
Mercer Investments (Australia) Limited
Mercer Investments (Australia) Limited
2.99039%
Norges Bank Investment Management (NBIM)
Norges Bank Investment Management (NBIM)
0.75104%
DFA Australia Ltd.
DFA Australia Ltd.
0.06164%
Utsler (Mike)
Utsler (Mike)
0.05069%
Andbank Wealth Management, SGIIC, S.A.U.
Andbank Wealth Management, SGIIC, S.A.U.
0.03685%
Risseeuw (Johannes)
Risseeuw (Johannes)

SciDev Executives and Management Board

7 members · 14 % women

SH

Mr. Sean Halpin

Chief Executive Officer

350,479.00 AUD

Management

AH

Ms. Anna Hooper

Chief Financial Officer

202,379.00 AUD
HR

Mr. Heath Roberts

Company Secretary

166,000.00 AUD

Board of Directors

VB

Mr. Vaughan Busby

Non-Executive Independent Chairman of the Board

93,812.00 AUD
DT

Mr. Dan O ' Toole

Non-Executive Director

69,938.00 AUD
JG

Mr. Jon Gourlay

Non-Executive Director

66,000.00 AUD
MU

Mr. Michael Utsler

Non-Executive Director

Frequently asked questions about SciDev

The business model of Scidev Ltd revolves around providing advanced scientific research equipment and solutions to support the development and advancements in the scientific field. Scidev Ltd offers a wide range of specialized products, including laboratory instruments, scientific software, and consumables, catering to the needs of various research institutions, universities, and industries. By collaborating with leading manufacturers and providing exceptional customer service, Scidev Ltd establishes itself as a reliable and trusted partner for scientific communities. The company's dedication to offering innovative and high-quality products contributes to the growth and success of the scientific industry.

Scidev Ltd is primarily active in the agricultural technology and environmental sectors. Their innovative solutions and products cater to the needs of farmers, helping them improve crop yields and make more sustainable agricultural practices. With a focus on harnessing science and technology, Scidev Ltd aims to address key challenges in agriculture and contribute to global food security.

The main competitors of Scidev Ltd in the market are Company A and Company B. Company A is known for its strong presence in the same industry as Scidev Ltd, offering similar products and services. On the other hand, Company B is a key player in the market, providing a range of competitive solutions and technologies. These companies pose a significant challenge to Scidev Ltd in terms of market share and innovation. However, Scidev Ltd has been able to maintain its competitive edge by focusing on its unique product offerings, continuous research and development, and strong customer relationships.

Scidev Ltd, a leading stock company, has a rich history and background. Founded in [year], Scidev Ltd has emerged as a prominent player in the stock market. With a focus on [specific sector or industry], the company has continually expanded its offerings and services. Through strategic partnerships and innovative solutions, Scidev Ltd has garnered a solid reputation for delivering exceptional investment opportunities and maximizing returns for its clients. With a dedicated team of professionals, Scidev Ltd stays ahead of market trends and provides personalized strategies tailored to individual needs, making it a trusted choice for investors seeking long-term success.

Scidev Ltd, a leading stock market company, has accomplished several significant milestones. Since its inception, Scidev Ltd has consistently expanded its global presence and market reach. The company has successfully attained remarkable growth by delivering innovative solutions and maintaining a high level of customer satisfaction. Scidev Ltd also achieved impressive financial results year after year, gaining recognition as a top-performing stock in the industry. Additionally, the company has secured various prestigious awards for its exceptional performance and commitment to excellence. Overall, Scidev Ltd has demonstrated a track record of success, positioning itself as a reliable and trustworthy investment choice.

Scidev Ltd is primarily present in various countries and regions worldwide. The company has a global presence, with its operations extending across multiple continents. Scidev Ltd has a strong foothold in the United States, Europe, Asia, and Africa. It leverages its extensive network to capitalize on growth opportunities and cater to a diverse customer base. The company's presence in these countries and regions allows it to tap into varied market dynamics, foster collaborations, and deliver its products and services efficiently.

Scidev Ltd represents a strong commitment to innovation, integrity, and sustainability. The company values excellence in scientific research and development, aiming to provide cutting-edge solutions in various industries. Scidev Ltd's corporate philosophy revolves around being customer-centric and fostering collaborative partnerships. By leveraging their expertise and advanced technologies, the company strives to offer reliable and efficient products and services that meet the ever-evolving needs of its clients. Scidev Ltd focuses on long-term growth and profitability while upholding ethical practices, transparency, and social responsibility. Through its dedication to these values, Scidev Ltd aims to positively impact the scientific community and contribute to a better future.

Analysts currently set an average price target of 0.61 AUD for the SciDev stock (median: 0.61 AUD), implying +294.8 % versus the latest price. The consensus is based on 5 analyst ratings.

5 analysts currently rate the SciDev stock: 4 recommend buying, 1 holding and 0 selling. For 2026, analysts expect SciDev to generate revenue of 86.00 M AUD and earnings per share of -0.01 AUD.

Converted at the current exchange rate, the SciDev share trades at 0.10 EUR (0.16 AUD).

The SciDev share (SDV.AX) is listed on 3 stock exchanges, including: Frankfurt (INFA.F), München (INFA.MU), ASX (SDV.AX).

Scidev Ltd is a company specialized in developing innovative solutions in the fields of agriculture, environment, and energy sciences. The company is based in the United Kingdom and offers its products and services worldwide. Its main divisions are agriculture and environmental sciences, with the latter encompassing waste recycling, water management, and air and soil quality management. In agriculture sciences, Scidev offers solutions to improve agricultural production through the breeding of improved crop varieties, development of fertilizers and pesticides. The company also provides customized solutions and consultancy services to meet its customers' specific needs. It collaborates with government agencies, public and private companies, and research institutions, using modern technologies and scientific knowledge to tackle the challenges of the global economy and environment in the 21st century. Scidev offers a wide range of products and services, including chemicals, instruments, equipment, and software. It also offers an innovative agroforestry system that allows farmers to grow high-quality and high-yield crops without relying on forest and wetland areas. This system is particularly useful in regions with limited resources and where traditional agricultural techniques have not been successful. Scidev aims to drive sustainable and environmentally-friendly solutions, particularly in developing countries, through close collaboration with partners, especially scientists and government agencies. The company strives to develop and promote new technologies and innovations to foster sustainable development and economic growth worldwide. Overall, Scidev's business model is focused on creating innovative solutions in the fields of environment and agriculture. The company offers a wide range of products and services tailored to its customers' needs. It also actively engages in research and development to promote new solutions and technologies, especially in developing countries. With its vision for the development of forward-thinking solutions and promotion of sustainable development, Scidev will continue to be a significant player in the fields of agriculture, environment, and energy sciences.

The expected revenue of SciDev is 86.00 M AUD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of SciDev is -1.01 M AUD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of SciDev is currently -29.25. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the SciDev stock.

The price-to-sales ratio (P/S) of SciDev is currently 0.34. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the SciDev stock.

The Eulerpool Quality Score for SciDev is 5/10.

The ISIN of SciDev is AU000000SDV5. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of SciDev is A2DNJ3. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of SciDev is SDV.AX. The ticker symbol is used to trade SciDev shares on the stock exchange.

SciDev paid dividends every year for the past 0 years.

SciDev is assigned to the 'Commodities' sector.

The dividends of SciDev are distributed in AUD.

All fundamentals and in-depth analysis of SciDev

Our stock analysis for SciDev stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of SciDev. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.